vs
KKR Real Estate Finance Trust Inc.（KREF）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是KKR Real Estate Finance Trust Inc.的1.1倍（$28.1M vs $25.8M），KKR Real Estate Finance Trust Inc.净利率更高（-101.7% vs -147.1%，领先45.4%），KKR Real Estate Finance Trust Inc.同比增速更快（-26.6% vs -67.6%）
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
KREF vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.1倍
$25.8M
营收增速更快
KREF
高出41.0%
-67.6%
净利率更高
KREF
高出45.4%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $28.1M |
| 净利润 | $-26.2M | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | -105.1% | -147.6% |
| 净利率 | -101.7% | -147.1% |
| 营收同比 | -26.6% | -67.6% |
| 净利润同比 | -229.6% | -182.8% |
| 每股收益（稀释后） | $-0.49 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KREFSPRY
| Q4 25 | $25.8M | $28.1M | ||
| Q3 25 | $25.3M | $32.5M | ||
| Q2 25 | $30.2M | $15.7M | ||
| Q1 25 | $31.3M | $8.0M | ||
| Q4 24 | $35.1M | $86.6M | ||
| Q3 24 | $37.0M | $2.1M | ||
| Q2 24 | $40.4M | $500.0K | ||
| Q1 24 | $39.1M | $0 |
净利润KREFSPRY
| Q4 25 | $-26.2M | $-41.3M | ||
| Q3 25 | $13.8M | $-51.2M | ||
| Q2 25 | $-29.7M | $-44.9M | ||
| Q1 25 | $-4.9M | $-33.9M | ||
| Q4 24 | $20.3M | $49.9M | ||
| Q3 24 | $-7.4M | $-19.1M | ||
| Q2 24 | $25.8M | $-12.5M | ||
| Q1 24 | $-3.1M | $-10.3M |
营业利润率KREFSPRY
| Q4 25 | -105.1% | -147.6% | ||
| Q3 25 | 50.4% | -163.7% | ||
| Q2 25 | -101.3% | -302.9% | ||
| Q1 25 | -18.3% | -466.3% | ||
| Q4 24 | 55.8% | 54.5% | ||
| Q3 24 | -19.6% | -1051.6% | ||
| Q2 24 | 63.3% | -3068.0% | ||
| Q1 24 | -8.7% | — |
净利率KREFSPRY
| Q4 25 | -101.7% | -147.1% | ||
| Q3 25 | 54.4% | -157.4% | ||
| Q2 25 | -98.5% | -285.6% | ||
| Q1 25 | -15.5% | -425.7% | ||
| Q4 24 | 57.7% | 57.7% | ||
| Q3 24 | -20.0% | -925.0% | ||
| Q2 24 | 63.9% | -2503.2% | ||
| Q1 24 | -7.9% | — |
每股收益（稀释后）KREFSPRY
| Q4 25 | $-0.49 | $-0.41 | ||
| Q3 25 | $0.12 | $-0.52 | ||
| Q2 25 | $-0.53 | $-0.46 | ||
| Q1 25 | $-0.15 | $-0.35 | ||
| Q4 24 | $0.22 | $0.52 | ||
| Q3 24 | $-0.19 | $-0.20 | ||
| Q2 24 | $0.29 | $-0.13 | ||
| Q1 24 | $-0.13 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $1.2B | $114.3M |
| 总资产 | $6.5B | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资KREFSPRY
| Q4 25 | $84.6M | $245.0M | ||
| Q3 25 | $204.1M | $288.2M | ||
| Q2 25 | $107.7M | $240.1M | ||
| Q1 25 | $106.4M | $275.7M | ||
| Q4 24 | $104.9M | $314.0M | ||
| Q3 24 | $108.8M | $204.6M | ||
| Q2 24 | $107.2M | $218.7M | ||
| Q1 24 | $106.5M | $223.6M |
总债务KREFSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KREFSPRY
| Q4 25 | $1.2B | $114.3M | ||
| Q3 25 | $1.2B | $147.7M | ||
| Q2 25 | $1.2B | $192.3M | ||
| Q1 25 | $1.3B | $229.0M | ||
| Q4 24 | $1.3B | $256.8M | ||
| Q3 24 | $1.4B | $201.0M | ||
| Q2 24 | $1.4B | $215.2M | ||
| Q1 24 | $1.4B | $223.9M |
总资产KREFSPRY
| Q4 25 | $6.5B | $327.7M | ||
| Q3 25 | $6.5B | $372.8M | ||
| Q2 25 | $6.8B | $313.5M | ||
| Q1 25 | $6.6B | $327.3M | ||
| Q4 24 | $6.4B | $351.2M | ||
| Q3 24 | $6.8B | $217.6M | ||
| Q2 24 | $7.1B | $222.0M | ||
| Q1 24 | $7.3B | $227.6M |
负债/权益比KREFSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KREFSPRY
| Q4 25 | $72.3M | $-43.5M | ||
| Q3 25 | $18.5M | $-47.0M | ||
| Q2 25 | $21.1M | $-39.6M | ||
| Q1 25 | $15.9M | $-40.7M | ||
| Q4 24 | $132.6M | $42.0M | ||
| Q3 24 | $49.1M | $-14.5M | ||
| Q2 24 | $30.6M | $-7.3M | ||
| Q1 24 | $34.5M | $-6.7M |
自由现金流KREFSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.8M |
自由现金流率KREFSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | — | — |
资本支出强度KREFSPRY
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | — |
现金转化率KREFSPRY
| Q4 25 | — | — | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KREF
暂无分部数据
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
